The Elecsys ApoE4 test is the first CE marked in-vitro diagnostic immunoassay to identify individuals carrying the ApoE4 genetic variant using a simple blood sample. The test offers a fast, reliable and accessible option to rapidly differentiate between carriers and non-carriers. The test...
Hence then, the article about roche receives ce mark for first ivd immunoassay blood test to identify carriers of apoe4 a genetic variant present in up to 60 of patients diagnosed with alzheimer s disease was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease )
Also on site :
- Gwyneth Paltrow’s surprisingly racy Oscars 2026 dress is slit all the way up the sides
- TIER IV unveils AI-based Level 4 autonomous driving, accelerating global platform expansion across Japan, U.S. and Europe
- Conan O’Brien Starts Oscars by Roasting Timothée Chalamet’s Ballet and Opera Controversy as Camera Cuts to ‘Marty Supreme’ Star Laughing